Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

EClinicalMedicine

Topics

Medicine

Immunology

Internal Medicine

Covid-19

Infectious Diseases

Show all topics

DOI

10.1016/j.eclinm.2020.100689

License

CC-BY-NC-ND

Other Formats

PDF